Acticor Biotech winner of the Prix Galien Medstartup in the category “BEST COLLABORATION IN THE PHARMACEUTICAL OR BIOTECHNOLOGICAL INDUSTRY”,organized by the prestigious Galien Foundation and by Business France.
Acticor Biotech announces FDA acceptance of its IND Application for Glenzocimab in Acute Ischemic Stroke